Home  »  Industry   »  Baudax Bio Inc. (BXRX) Quarterly Performance is -4...

Baudax Bio Inc. (BXRX) Quarterly Performance is -43.70%: Here is the Surprise Factor

At the end of the latest market close, Baudax Bio Inc. (BXRX) was valued at $1.33. In that particular session, Stock kicked-off at the price of $1.39 while reaching the peak value of $1.43 and lowest value recorded on the day was $1.25. The stock current value is $1.75.Recently in News on February 23, 2023, Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update. Company Focuses on Development of Neuromuscular Blocking Agents. You can read further details here

Baudax Bio Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $91.2000 on 03/23/22, with the lowest value was $1.2500 for the same time period, recorded on 03/15/23.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


Baudax Bio Inc. (BXRX) full year performance was -97.30%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Baudax Bio Inc. shares are logging -98.08% during the 52-week period from high price, and 40.07% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.25 and $91.20.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4178865 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Baudax Bio Inc. (BXRX) recorded performance in the market was -44.94%, having the revenues showcasing -43.70% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 4.00M, as it employees total of 9 workers.

The Analysts eye on Baudax Bio Inc. (BXRX)

During the last month, 0 analysts gave the Baudax Bio Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.9159, with a change in the price was noted -5.83. In a similar fashion, Baudax Bio Inc. posted a movement of -75.32% for the period of last 100 days, recording 1,406,486 in trading volumes.

Technical rundown of Baudax Bio Inc. (BXRX)

Raw Stochastic average of Baudax Bio Inc. in the period of last 50 days is set at 11.70%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 36.87%. In the last 20 days, the company’s Stochastic %K was 15.32% and its Stochastic %D was recorded 7.86%.

Considering, the past performance of Baudax Bio Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -44.94%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -86.83%, alongside a downfall of -97.30% for the period of the last 12 months. The shares increased approximately by 9.43% in the 7-day charts and went up by -31.87% in the period of the last 30 days. Common stock shares were lifted by -43.70% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts